| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 22.97▼ | 22.97▼ | 22.97▼ | 23.14▼ | 22.90▲ |
| MA10 | 23.11▼ | 23.15▼ | 23.15▼ | 23.02▼ | 22.53▲ |
| MA20 | 23.19▼ | 23.16▼ | 23.14▼ | 22.86▲ | 21.88▲ |
| MA50 | 23.15▼ | 23.01▼ | 22.84▲ | 22.44▲ | 21.40▲ |
| MA100 | 22.83▲ | 22.81▲ | 22.75▲ | 21.82▲ | 20.72▲ |
| MA200 | 22.71▲ | 22.62▲ | 22.45▲ | 21.46▲ | 23.21▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.055▼ | -0.057▼ | -0.061▼ | 0.004▲ | 0.123▲ |
| RSI | 34.823▼ | 38.831▼ | 42.877▼ | 53.771▲ | 62.990▲ |
| STOCH | 1.283▼ | 3.271▼ | 3.266▼ | 74.419 | 81.287▲ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -50.382 | -28.821 |
| CCI | -93.230 | -95.638 | -100.800▼ | 15.017 | 111.652▲ |
| MA | $COMB Price Crossed Below MA(7) | Set Alert |
|
Friday, September 27, 2024 05:13 AM
On Friday, Johnson & Johnson (NYSE:JNJ) released updated results from the investigational Phase 1b RedirecTT-1 study evaluating the combination of Talvey (talquetamab) and Tecvayli (teclistamab) in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/12/25 | 22.97 | 23.00 | 22.91 | 22.91 | 32,150 |
| 08/12/25 | 23.21 | 23.213 | 23.01 | 23.03 | 26,700 |
| 05/12/25 | 23.50 | 23.57 | 23.38 | 23.394 | 14,000 |
| 04/12/25 | 23.13 | 23.2299 | 23.02 | 23.2213 | 9,542 |
| 03/12/25 | 23.18 | 23.22 | 23.1255 | 23.135 | 38,595 |
| 02/12/25 | 23.17 | 23.17 | 23.029 | 23.07 | 32,700 |
| 01/12/25 | 23.11 | 23.26 | 23.082 | 23.17 | 520,900 |
| 28/11/25 | 22.89 | 23.09 | 22.89 | 23.09 | 25,467 |
| 26/11/25 | 22.55 | 22.74 | 22.53 | 22.74 | 20,300 |
| 25/11/25 | 22.33 | 22.42 | 22.26 | 22.40 | 104,400 |
|
|
||||
|
|
||||
|
|